Documentos de Knight M.L. | REDI

Regresar

Mostrando 4 resultados de: 4

Filtros aplicados

Palabras Claves: "SARS-COV-2"

Subtipo de publicación

Publisher

EMBO Reports(1)

Wellcome Open Research(1)

Área temáticas

Enfermedades(3)

Microorganismos, hongos y algas(3)

Farmacología y terapéutica(2)

Medicina y salud(2)

Medicina forense; incidencia de enfermedades(1)

Área de conocimiento

Inmunología(3)

Microbiología(1)

Año de Publicación

Origen

Palabras Claves

A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy

Abstract: In the absence of a proven effective vaccine preventing infection by SARS-CoV-2, or a proven drug to

Palabras claves:

antibody-ACE2 fusion, Biparatopic, covid-19, neutralizing antibody, SARS-COV-2

Chen C., Chen L., Fu W., Gao W., Huang X., James W.S., Javier Gilbert Jaramillo, Jiang W., Knight M.L., Lee S.M.Y., Liu X., Luo Y., Miao X., Pang T., Rijal P., Song X., Sun J., Tan T.K., Tang Y., Townsend A.R., Tsun A., Wan L., Wang C., Wu F., Xu Y., Yan Y., Yuan Z., Zou Y.

Inclusion of cGAMP within virus-like particle vaccines enhances their immunogenicity

Abstract: Cyclic GMP-AMP (cGAMP) is an immunostimulatory molecule produced by cGAS that activates STING. cGAMP

Palabras claves:

cGAMP, Influenza a virus, SARS-COV-2, type I interferon, viral vaccine vector

Beveridge R., Borrow P., Bridgeman A., Chauveau L., Drakesmith H., Frost J.N., Javier Gilbert Jaramillo, Knight M.L., Liu X., Partridge T., Pedroza-Pacheco I., Rehwinkel J., Rijal P., Russell R.A., Tan T.K., Townsend A.R.

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Abstract: Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was introduced in the

Palabras claves:

antibody, B cell, BNT162b2, covid-19, dosing interval, Neutralization, SARS-COV-2, T cell, Vaccine, variants of concern

Abuelgasim H., Adele S., Adland E., Adlou S., Akther H.D., Al-Taei S., Alhussni A., Ali M., Altmann T., Amini A., Angyal A., Arancibia-Cárcamo C.V., Austin J.A., Azim Ansari M., Barnes E., Bayley M., Bridges-Webb A., Brown A., Brown H., Brown R., Carroll M.W., Chalk J., Chand M., Chawla A., Chinnakannan S., Conlon C.P., Cross A., Cutteridge J., de Lara C., de Silva T.I., Deeks A.S., Dejnirattisai W., Denly L., Diffey B., Dimitriadis S., Dobson S.L., Dold C., Donnison T., Drake T.M., Dunachie S.J., Duncan C.J.A., Dupont M., Eyre D.W., Fairman A., Faustini S., Foulkes S., Frater J., Gardiner S., Gillson N., Goulder P., Hackstein C.P., Hall V., Hambleton S., Haniffa M., Hargreaves A., Haworth J., Hering L.M., Holmes J., Hopkins S., Horner E., Hornsby H., Jämsén A., Javier Gilbert Jaramillo, Jeffery K., Johnson S.A., Jones C., Kasanyinga M., Kelly S., Kilby J.A., Kirk R., Klenerman P., Knight M.L., Lawrie A., Lee L., Linder A., Longet S., Malone T., Matthews P.C., Meardon N., Mongkolsapaya J., Moore S.C., Nicols A.R., Payne R.P., Phillips E., Pollard A.J., Reyes L.S., Richter A., Rowland-Jones S.L., Saei A., Sandhar G., Screaton G.R., Shields A., Skelly D.T., Stafford L., Supasa P., Tipton T., Turtle L., Tyerman J.K., Whitham R., Wootton D.G.

SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus

Abstract: Background: Laboratory diagnosis of SARS-CoV-2 infection (the cause of COVID-19) uses PCR to detect

Palabras claves:

Biomarker, Blood, covid-19, Laboratory safety, RNA, SARS-COV-2, Viraemia, Viral load

Andersson M.I., Arancibia-Cárcamo C.V., Auckland K., Baillie J.K., Barnes E., Beneke T., Bibi S., Brooks T.J.G., Carroll M.W., Crook D.W., Dingle K., Dold C., Downs L.O., Dunn L., Eyre D.W., Harvala H., Hoosdally S., Ijaz S., James T., James W.S., Javier Gilbert Jaramillo, Jeffery K., Justice A., Klenerman P., Knight J.C., Knight M.L., Liu X., Lumley S.F., Matthews P.C., McNaughton A.L., Mentzer A.J., Mongkolsapaya J., Oakley S., Oliveira M.S., Peto T., Ploeg R.J., Ratcliff J., Robbins M.J., Roberts D.J., Rudkin J., Russell R.A., Screaton G.R., Semple M.G., Simmonds P., Skelly D.T., Stoesser N., Turtle L., Wareing S., Zambon M.